Hint mode is switched on Switch off

Verastem, ordinary share
VSTM, US92337C1045

Add a stock to WL
Choose all Reset all
Verastem, сountry — USA
01/06/2023 stock stopped trading due to affiliation to Verastem, ordinary share
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

  • Issuer
  • Full borrower / issuer name
    Verastem Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    VSTM
  • Placement
    27.01.2012
  • Lock up period
    180
  • Number of papers
    5,500,000
  • Volume of raised funds
    55 mln USD
  • Final placement price
    10 USD
  • Price change since placement date
    -100%
  • By capitalization
    202.34 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    VSTM
  • Placement
    23.01.2015
  • Lock up period
    180
  • Number of papers
    7,250,000
  • Volume of raised funds
    47.13 mln USD
  • Placement share
    21.87%
  • Final placement price
    6.5 USD
  • Price change since placement date
    -100%
  • By capitalization
    215.44 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    VSTM
  • Placement
    18.12.2017
  • Lock up period
    180
  • Number of papers
    8,422,877
  • Volume of raised funds
    32.01 mln USD
  • Placement share
    17.41%
  • Final placement price
    3.8 USD
  • Price change since placement date
    -100%
  • By capitalization
    183.8 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    VSTM
  • Placement
    24.07.2024
  • Lock up period
    180
  • Number of papers
    13,333,334
  • Volume of raised funds
    40 mln USD
  • Placement share
    34.51%
  • Final placement price
    3 USD
  • Price change since placement date
    -100%
  • By capitalization
    115.92 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Indicators

News

23/07/2026 Verastem Oncology to Report Second Quarter 2026 Financial Results on August 6, 2026
21/05/2026 Verastem: Submission Of Matters To A Vote Of Security Holders
23/04/2026 Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026
04/03/2026 Verastem Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Business Updates
18/02/2026 Verastem Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
All organization news

Other stocks and deposit receipts

Domestic and international bonds of the issuer

Holders

Industry Leaders

Registration is required to get access.